Notis Mc Conarty Edward Novartis Ag Transaction History

Notis Mc Conarty Edward

  • $217 Million
  • Q3 2024

A detailed history of Notis Mc Conarty Edward transactions in Novartis Ag stock. As of the latest transaction made, Notis Mc Conarty Edward holds 3,715 shares of NVS stock, worth $391,821. This represents 0.2% of its overall portfolio holdings.

Number of Shares
3,715
Previous 10,861 65.8%
Holding current value
$391,821
Previous $1.16 Million 63.06%
% of portfolio
0.2%
Previous 0.46%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$106.13 - $120.89 $758,404 - $863,879
-7,146 Reduced 65.8%
3,715 $427,000
Q2 2024

Aug 12, 2024
SELL
$92.57 - $107.37 $1.23 Million - $1.43 Million
-13,300 Reduced 55.05%
10,861 $1.16 Million
Q1 2024

Apr 29, 2024
SELL
$95.27 - $108.47 $1.2 Million - $1.36 Million
-12,570 Reduced 34.22%
24,161 $2.34 Million
Q4 2023

Feb 13, 2024
SELL
$92.27 - $101.54 $490,876 - $540,192
-5,320 Reduced 12.65%
36,731 $3.71 Million
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $89,046 - $98,822
-940 Reduced 2.19%
42,051 $4.28 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $23,130 - $26,227
-250 Reduced 0.58%
42,991 $4.34 Million
Q1 2023

May 10, 2023
SELL
$80.03 - $92.81 $35,213 - $40,836
-440 Reduced 1.01%
43,241 $3.98 Million
Q4 2022

Feb 09, 2023
SELL
$75.55 - $92.52 $1,133 - $1,387
-15 Reduced 0.03%
43,681 $3.96 Million
Q3 2022

Nov 08, 2022
SELL
$74.61 - $87.26 $33,052 - $38,656
-443 Reduced 1.0%
43,696 $3.32 Million
Q2 2022

Jul 19, 2022
BUY
$80.52 - $93.75 $11,675 - $13,593
145 Added 0.33%
44,139 $3.73 Million
Q1 2022

May 17, 2022
BUY
$80.11 - $90.62 $6,408 - $7,249
80 Added 0.18%
43,994 $3.86 Million
Q4 2021

Feb 08, 2022
SELL
$79.7 - $88.13 $159,160 - $175,995
-1,997 Reduced 4.35%
43,914 $3.84 Million
Q3 2021

Nov 10, 2021
BUY
$81.78 - $95.14 $137,799 - $160,310
1,685 Added 3.81%
45,911 $3.76 Million
Q2 2021

Aug 09, 2021
SELL
$85.24 - $94.15 $52,337 - $57,808
-614 Reduced 1.37%
44,226 $4.03 Million
Q1 2021

May 17, 2021
BUY
$83.5 - $98.47 $20,875 - $24,617
250 Added 0.56%
44,840 $3.83 Million
Q4 2020

Feb 16, 2021
BUY
$78.07 - $94.43 $50,355 - $60,907
645 Added 1.47%
44,590 $4.21 Million
Q3 2020

Oct 28, 2020
BUY
$82.14 - $91.0 $13,142 - $14,560
160 Added 0.37%
43,945 $3.82 Million
Q2 2020

Jul 28, 2020
BUY
$80.93 - $91.1 $46,939 - $52,838
580 Added 1.34%
43,785 $3.82 Million
Q1 2020

May 07, 2020
BUY
$70.67 - $99.01 $18,020 - $25,247
255 Added 0.59%
43,205 $3.56 Million
Q4 2019

Jan 15, 2020
SELL
$84.35 - $95.37 $15,182 - $17,166
-180 Reduced 0.42%
42,950 $4.07 Million
Q3 2019

Nov 04, 2019
SELL
$85.54 - $94.26 $31,222 - $34,404
-365 Reduced 0.84%
43,130 $3.75 Million
Q2 2019

Jul 24, 2019
BUY
$75.4 - $92.8 $1,885 - $2,320
25 Added 0.06%
43,495 $3.97 Million
Q1 2019

Apr 29, 2019
BUY
$75.32 - $86.15 $11,674 - $13,353
155 Added 0.36%
43,470 $4.18 Million
Q4 2018

Jan 24, 2019
SELL
$73.66 - $82.02 $11,417 - $12,713
-155 Reduced 0.36%
43,315 $3.72 Million
Q3 2018

Oct 15, 2018
BUY
$66.94 - $77.43 $135,553 - $156,795
2,025 Added 4.89%
43,470 $3.75 Million
Q2 2018

Jul 30, 2018
BUY
$64.91 - $73.36 $85,356 - $96,468
1,315 Added 3.28%
41,445 $3.13 Million
Q1 2018

Apr 24, 2018
BUY
$70.39 - $84.15 $56,663 - $67,740
805 Added 2.05%
40,130 $3.25 Million
Q4 2017

Feb 02, 2018
BUY
$72.33 - $77.64 $296,553 - $318,324
4,100 Added 11.64%
39,325 $3.3 Million
Q3 2017

Oct 26, 2017
BUY
$74.14 - $77.27 $2.61 Million - $2.72 Million
35,225
35,225 $3.02 Million

Others Institutions Holding NVS

# of Institutions
1,430
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $227B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Notis Mc Conarty Edward Portfolio

Follow Notis Mc Conarty Edward and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Notis Mc Conarty Edward, based on Form 13F filings with the SEC.

News

Stay updated on Notis Mc Conarty Edward with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email